Loading…
Based on limited metadata, Luen Fook Medicine Sdn. Bhd., a drug manufacturer, received an FDA Warning Letter on April 4, 2019. While the specific violations cannot be detailed without access to the full letter text, the warning indicates compliance issues with FDA drug regulations. The letter falls under FDA's drug product oversight, though the specific manufacturing or quality control deficiencies are not identifiable from the available metadata alone.